NovaBiotics at the 7th International Meeting on Antimicrobial Peptides

NovaBiotics sponsoring and participating in the 7th International Meeting on Antimicrobial Peptides (IMAP) at the University of Copenhagen next week (25th – 27th August).

The team will be hosting a series of talks throughout the conference and will be presenting updates on NovaBiotics’ drug portfolio.

Details of NovaBiotics’ oral presentations and posters on novel, AMR-mitigating antibacterial and antifungal agents are as follows:

Friday 25th August, 12.05pm, presentation

Antifungal Activity of NP339: A Novel Antifugal Peptide

Friday 25th August, 16.30pm, poster sessions

Antifungal Activity of NP339: A Novel Antifugal Peptide

NP108, a broad-spectrum antimicrobial polymer in development for the treatment of wound infections

NP432, a novel antimicrobial peptide rapidly active against multi-drug resistant bacteria

 Saturday 26th August, 09.00am, presentation

Next generation synthetic AMP for fungal and bacterial disease


Saturday 26th August, 14.40pm, presentation

Novexatin (NP213); A cyclic antifungal peptide in development for the treatment of onychomycosis